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Elizabethkingia infections are difficult to treat because of 
intrinsic antimicrobial resistance, and their incidence has 
recently increased. We conducted a propensity score–
matched case–control study during January 2016–June 
2017 in South Korea and retrospectively studied data 
from patients who were culture positive for Elizabethkingia 
species during January 2009–June 2017. Furthermore, we 
conducted epidemiologic studies of the hospital environment 
and mosquitoes. The incidence of Elizabethkingia increased 
significantly, by 432.1%, for 2016–2017 over incidence 
for 2009–2015. Mechanical ventilation was associated 
with the acquisition of Elizabethkingia species. Because 
Elizabethkingia infection has a high case-fatality rate and is 
difficult to eliminate, intensive prevention of contamination 
is needed.
The genus Elizabethkingia comprises glucose-nonfer-menting, gram-negative rods that are widely distrib-
uted in natural environments, including in soil and fresh-
water, and in hospital environments (1). E. meningoseptica 
(originally named Chryseobacterium meningoseptica) has 
been associated with opportunistic infections, such as sep-
sis in immunocompromised patients and meningitis in neo-
nates (2). Two new species of Elizabethkingia have been 
proposed: E. miricola, which was first isolated from wa-
ter from the Russian space station MIR in 2003 (3,4); and 
E. anophelis, which was first isolated from the midgut of 
the Anopheles gambiae mosquito in 2011 (5). Because E. 
anophelis was the most frequently isolated Elizabethkingia 
species in recent clinical studies, as confirmed by 16s 
rRNA gene sequencing (6,7), but is commonly misidenti-
fied as E. meningoseptica, many previously reported cases 
of E. meningoseptica could actually have been caused by 
E. anophelis (8,9).
Infection caused by Elizabethkingia species is difficult 
to treat and results in a high case-fatality rate, probably 
because of intrinsic antimicrobial resistance (10). E. 
meningoseptica has been documented to carry class A 
extended-spectrum β-lactamases and 2 chromosomal 
metallo-β-lactamases (11,12).
Some outbreaks of Elizabethkingia species have 
been reported to have resulted from a contaminated water 
source (13–15). Furthermore, recent increases in the annual 
incidence of Elizabethkingia species. have been reported 
in many countries (14,16–19). However, knowledge 
about host risk factors associated with the acquisition 
of Elizabethkingia species is lacking, and no evidence 
exists that mosquitoes or other sources act as vectors in 
transmitting it to humans. Thus, we investigated the annual 
incidence and clinical characteristics of Elizabethkingia 
acquisition in a tertiary teaching hospital in Seoul, South 
Korea. We aimed to determine whether the incidence of 
Elizabethkingia species had increased in this hospital and 
to analyze the risk factors associated with Elizabethkingia 
acquisition. To identify the source of Elizabethkingia, we 
obtained and analyzed epidemiologic studies from the 
hospital environment and mosquitoes.
Methods
Study Participants
We retrospectively collected data from all nonduplicate 
persons who had positive culture results for Elizabethkingia 
species from Severance Hospital, a >2,000-bed tertiary 
teaching hospital in South Korea, during January 1, 2009–
June 30, 2017. The hospital had 10 intensive care units 
(ICUs) for adults and 2 for children. During this period, the 
annual number of inpatient-days was >670,000.
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Elizabethkingia Acquisition, South Korea
Because we had identified strains in our previous study 
(7), we updated our in-house library of matrix-assisted la-
ser desorption/ionization time-of-flight mass spectrometry 
(MS) (Bruker Daltonic GmbH, https://www.bruker.com). 
Elizabethkingia species were identified by 2 matrix-assist-
ed laser desorption/ionization time-of-flight MS systems; 
the Bruker MS used the updated in-house library and the 
Vitek MS (bioMèrieux, https://www.biomerieux.com) 
used the latest version of IVD (in vitro diagnostic database) 
V3.2. Strains with discrepant results were confirmed by 
16S rRNA gene sequencing using universal primers.
We collected the following clinical data using elec-
tronic medical records: age-adjusted Charlson comor-
bidity index (20), sex, sites of specimen collection, date 
of specimen collection, date of patient death, pulse rate, 
oxygen saturation, body temperature, chest radiograph 
results, and any antimicrobial agents administered dur-
ing hospitalization. We also obtained available labora-
tory findings from the same day as specimen collection 
and within 7 days from the same day as specimen col-
lection, including C-reactive protein level, erythrocyte 
sedimentation rate, and leukocyte count. The Institution-
al Review Board at Severance Hospital, affiliated with 
Yonsei University Health System (2017–2101–001), ap-
proved this study.
Epidemiologic Study of Environmental Sources  
and Mosquitoes
We obtained extensive surveillance cultures of 281 common 
environmental sources by swab culture of equipment and 
surfaces within patient rooms, restrooms, nursing stations, 
electronics, furniture, patient care devices, patient transport 
carts, sinks, and water taps. Additionally, during July–
September 2017, we collected adult mosquitoes in 1 urban 
site (Seodaemun-gu, Seoul, where Severance Hospital is 
located) and 3 rural areas (Hwaseong-si, Gyeonggi-do; 
Paju-si, Gyeonggi-do; and Chungju-si, Chungbuk, where 
annual zoonotic disease monitoring had taken place for their 
dense population of animal farms) (Figure 1). Mosquitoes 
were collected using Insect Light Traps Model SR-2000 
(Sin Young Inc., Seoul, South Korea) and identified under 
a stereomicroscope after cold anesthesia, as in the previous 
study (21).
All swab samples and midguts of mosquitoes were 
inoculated on sheep blood agar and MacConkey agar 
and incubated overnight. DNA was extracted from 
mosquitoes using a simple boiling method, and PCR was 
performed using Elizabethkingia species–specific primers 
(forward, GAACACGTGTGCAACCTGCC; reverse, 
TCCAGCCACTTCAACCTTAC) and the following cycle 
parameters: 95°C for 5 min, followed by 35 cycles of 95°C 
for 30 s, 58°C for 2 min, and 72°C for 1 min; followed by a 
final extension step at 72°C for 7 min (22).
Pulsed-Field Gel Electrophoresis
We conducted pulsed-field gel electrophoresis (PFGE) 
analysis of XbaI-digested isolated chromosomal DNA 
from a total of 12 strains isolated from the environment (7 
E. anophelis, 3 E. miricola, 2 E. meningoseptica) and 54 
stored strains isolated from inpatients since 2017. PFGE 
patterns were analyzed using the CHEF DR II system (Bio-
Rad, http://www.bio-rad.com) as previously described (9).
Definition
We defined true pathogen cases according to the definitions 
of Moore et al. and the Centers for Disease Control and 
Prevention. In brief, we defined these cases as patients with 
the monomicrobial acquisition of Elizabethkingia species 
and 1 of the following parameters within 2 days before and 
after acquisition without any other recognized cause: body 
temperature <36°C or >38°C, pulse rate >90 beats/min 
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Figure 1. Rural areas of South Korea (Hwaseong-si, Gyeonggi-do; 
Paju-si, Gyeonggi-do; and Chungju-si, Chungbuk) where adult 
mosquitoes were collected during July–September 2017 and the 
urban location of the tertiary teaching hospital (Seodaemun-gu, 
Seoul) where the study of Elizabethkingia infection in patients was 
conducted during January 2009–June 2017.
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(reference range 60–100 beats/min), leukocyte count <4 or 
>12 × 109 cells/L (reference range 4.0–10.9 × 109 cells/L), 
C-reactive protein >100 mg/L (reference range 0–8 mg/L), 
or chest radiography showing new pulmonary infiltrations 
(13,23). According to previous studies, outbreaks are deter-
mined by whether they exceed 2 SD of the previous disease 
incidence (24,25).
Propensity Score–Matched Analysis
After 2016, the incidence of isolated Elizabethkingia 
species increased significantly. To analyze the increased 
incidence, we conducted surveillance culture study and 
compared clinical characteristics of patients who acquired 
Elizabethkingia species before and after 2016. In both the 
surveillance culture study and the statistical analysis, only 
3 study wards showed positive results for the acquisition 
of Elizabethkingia: an ICU (ICU 1, 18 beds) used for 
cardiovascular disease, an isolation ward (ward A, 50 beds) 
used for patients with vancomycin-resistant Enterococcus, 
and a general ward (ward B, 50 beds) used for pulmonary 
disease patients. A total of 6,583 patients have been 
hospitalized in these wards since 2016.
To adjust confounding factors for the acquisition of 
Elizabethkingia species, we conducted a propensity score 
(PS)–matched case–control study. We defined case-pa-
tients as patients with Elizabethkingia species isolated from 
any clinical specimens during January 2016–June 2017 in 
ICU 1, ward A, or ward B and control patients as patients 
without Elizabethkingia species in these 3 study wards. We 
selected 3 variables—hospital ward (p<0.001), period of 
admission (p = 0.041), and length of stay in the 3 study 
wards (p<0.001)—for adjustment by univariate analysis 
(26,27). We estimated a PS for the predicted probability of 
acquisition of Elizabethkingia species in each patient us-
ing the logistic regression model. Then we performed a PS-
matched analysis by attempting to match case-patients and 
control patients (1:3 match) using the nearest-neighbor-
matching method. A match occurred when the difference 
in the logits of the PS was <0.2 times the SD of the scores.
Statistical Analysis
We assessed all variables using the Shapiro-Wilk test to 
evaluate Gaussian distributions. Descriptive statistics 
are presented as a median and interquartile range (IQR) 
for continuous variables or numbers and percentage for 
categorical variables. Comparisons between groups were 
analyzed using the Mann-Whitney U test for continuous 
variables and the Fisher exact test for categorical variables.
Using conditional logistic regression, we conducted 
univariate and multivariate regressions between case-
patients and control patients of the 3 study wards. 
Dependent variables included in the multivariate analysis 
were selected based on statistical significance provided by 
univariate analysis. Incidence rate ratios and 95% CIs were 
calculated by comparing the mean incidences between 
2009–2015 and 2016–2017 by Poisson regression.
All reported p values are 2-tailed, and p values <0.05 
indicate statistical significance. We conducted statisti-
cal analyses using R statistical software (R Studio, Inc., 
 https://www.r-project.org).
Results
The annual incidence of Elizabethkingia acquisition in 
Severance Hospital increased in 2011 (Table 1; Figure 2). 
According to the defined threshold, years with incidence >2 
SD were 2011, 2012, 2013, 2014, and 2016. In particular, 
incidence increased most significantly to 109.82 cases/1 
million inpatient-days in 2016 (p<0.001). An additional 
50 cases were reported during January–June 2017, which 
corresponded to 127.79 cases/1 million inpatient-days. The 
acquisition incidence of Elizabethkingia species increased 
significantly, by 432.1%, during 2016–2017 over the ac-
quisition incidence during 2009–2015 (relative risk [RR] 
4.17, 95% CI 3.28–5.29; p<0.001), mainly because of the 
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Table 1. Annual incidence and characteristics of Elizabethkingia acquisitions at a tertiary teaching hospital, Seoul, South Korea 
Characteristic 2009 2010 2011 2012 2013 2014 2015 2016 
2017 
Jan–Jun 
No. cases 2 2 10 23 29 39 30 84 50 
Incidence          
 Per 1 million inpatient-days 2.93 2.98 14.60 33.14 42.43 55.74 40.66 109.82 127.79 
 Per 1,000 inpatients 0.02 0.02 0.10 0.23 0.30 0.39 0.28 0.75 0.88 
Sample type, no., may be multiple 
         
 Respiratory 2 0 2 14 25 27 26 76 48 
 Blood culture 0 2 2 2 2 3 1 4 3 
 Urine culture 0 0 5 2 2 3 1 1 0 
 Other* 0 0 1 5 1 7 2 6 1 
Species, no.          
 E. anophelis 1 2 2 7 16 17 15 45 34 
 E miricola 0 0 5 1 4 5 11 25 12 
 E. meningoseptica 1 0 3 3 5 4 1 4 2 
 Unconfirmed† 0 0 0 12 4 13 3 10 2 
*Includes 12 from body fluids, 4 wound swabs, 3 catheter tips, 2 oral swabs, 1 eye swab, and 1 ear swab. 
†Includes strains that were not stored for identification. 
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increase in strains isolated from respiratory specimens (in-
cidence rate ratio 3.22, 95% CI 2.46–4.20; p<0.001).
We identified 269 patients who acquired Elizabeth-
kingia species during January 2009–June 2017, of whom 
134 (49.8%) were reported during 2016–June 2017 (Table 2, 
https://wwwnc.cdc.gov/EID/article/25/1/17-1985-T2.htm). 
Patients who acquired Elizabethkingia during 2016–June 
2017 were more frequently classified as having contracted 
a nosocomial infection than were patients who acquired 
Elizabethkingia during 2009–2015. The number of cases in 
the 3 study wards increased significantly but not in the other 
wards. In addition, more patients with chronic pulmonary 
disease or diabetes mellitus were seen during 2016–2017. 
More patients had a history of mechanical ventilation, a 
longer length of hospital stay, and a history of steroid use 
during 2009–2015 than during 2016–2017.
Surveillance Studies
We isolated 12 Elizabethkingia strains; all were derived 
from the 3 study wards. Seven E. anophelis isolates (4 from 
water taps in ICU 1, 2 from washbasins in ICU 1, and 1 
from the suction regulator in ward A), 3 E. miricola isolates 
(3 from washbasins in ward A), and 2 E. meningoseptica 
isolates (1 from the mechanical ventilator after removal 
from a patient and 1 from the suction regulator in ward B) 
were identified by surveillance cultures.
We conducted PFGE typing on 54 clinical isolates 
(40 E. anophelis, 10 E. miricola, and 4 E. meningoseptica) 
from inpatients and 7 E. anophelis, 3 E. miricola, and 2 
E. meningoseptica isolates from environmental samples. 
PFGE patterns showed that E. anophelis isolates belonged 
to 8 different PFGE groups, E. miricola to 4 groups, and 
E. meningoseptica to 2 groups (Figure 3). Five patients 
with E. anophelis (1 patient from ward B and 4 patients 
from other locations) had a history of admission to ICU 
1 (Figure 3, panel A). Of patients from other locations, 1 
had a history of admission to ward A and 2 had histories of 
admission to ward B. One patient in ICU 1 had moved from 
ward A, where the major cluster of environmental samples 
was isolated (Figure 3, panel B). Similarly, 1 patient in 
ICU 1 was transferred from ward B (Figure 3, panel C). 
This patient’s history of ward transfers suggests that 
transmission of the bacteria from patient to patient might 
be a cause of spreading. However, we cannot rule out the 
existence of other environmental sources.
We conducted PCR on 30 Anopheles sinensis, 8 
Culex tritaeniorhynchus, and 3 Aedes vexans mosquitoes 
and on surveillance cultures collected from the midgut of 
mosquitoes. All yielded negative results.
Epidemiologic Results Before and After PS Matching
Of the 6,583 patients potentially exposed on the 3 study 
wards, 74 were colonized or infected with Elizabethkingia 
species (Table 3). Case-patients and control-patients 
differed significantly in the proportion of hospitalized 
wards. The case-patient group, had higher admission 
rates to ward A and ward B, whereas control-patients had 
a higher rate of admission to ICU 1. Furthermore, case-
patients had a significantly longer stay in the 3 study 
wards than did control-patients. In the 3 study wards, 
case-patients spent a median of 55 days (IQR 20–131 
days), significantly longer than that of control patients (3 
days [IQR 2–8 days]; p<0.001).
We conducted PS matching to adjust baseline demo-
graphics and clinical variables between the case-patient 
and control-patient groups. PS matching resulted in 52 
matched pairs at a 1:3 ratio. After matching, we included 
52 of 74 case-patients in the analysis. Confounding vari-
ables were well balanced in the 2 groups, including hospi-
talization ward and the period of admission and length of 
stay in the 3 study wards. Furthermore, the 2 comorbidi-
ties after PS matching did not differ significantly because 
there was an adjustment to the proportions of admission 
to ward A, which had high rates of patients with hema-
tologic malignancy, and ward B, which had high rates of 
patients with chronic pulmonary disease. However, use of 
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Figure 2. Trends in the quarterly incidence of Elizabethkingia 
infection or colonization in a tertiary teaching hospital, Seoul, 
South Korea, January 2009–June 2017. Q1, January–March; Q2, 
April–June; Q3, July–September; Q4, October–December.
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Figure 3. Pulsed-field gel electrophoresis dendrograms for 54 clinical isolates and 12 environmental isolates of Elizabethkingia species, 
Seoul, South Korea, 2017. E. anophelis (40 clinical isolates and 7 environmental isolates) showed 8 pulsotypes (A), E. miricola (10 
clinical isolates and 3 environmental isolates) 4 pulsotypes (B), and E. meningoseptica (4 clinical isolates and 2 environmental isolates) 
2 pulsotypes (C). c, clinical; e, environmental; ICU, intensive care unit. Scale bar indicates percent relatedness.
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mechanical ventilation still differed significantly after PS 
matching (p<0.001).
We used univariate and multivariate analyses with 
conditional logistic regression to identify independent 
risk factors (Table 4). Only use of mechanical ventilation 
(adjusted odds ratio [OR] 50.44 [95% CI 6.74–377.48]; 
p<0.001) was associated with the acquisition of Elizabeth-
kingia species.
Only 30 patients were classified as true pathogen cases 
(Table 5). In the hospital mortality group, the median total 
hospitalization stay was longer than that of the nonhospi-
tal mortality group (77.5 vs. 38.5 days; p = 0.04). More 
case-patients were treated with carbapenem or trime-
thoprim/sulfamethoxazole than were those in the nonhos-
pital mortality group (5 vs. 2 case-patients; p = 0.05).
Discussion
The incidence of infection with Elizabethkingia species 
has increased in recent years in many countries (14,16–
19). Furthermore, a large-scale outbreak was reported in 
community settings in the United States (28).
In previous studies, the reported annual incidence of E. 
meningoseptica ranged from 0.007 to 0.399 cases per 1,000 
admissions (19,29). We reported the antimicrobial resistance 
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Table 3. Variables possibly associated with acquisition of Elizabethkingia species, before and after propensity score matching, in a 
tertiary teaching hospital, Seoul, South Korea 
Variable 
Before matching 
 
After matching 
Case-patients, n 
= 74 
Control-patients, 
n = 6,509 p value 
Case-patients, n 
= 52 
Control-patients, 
n = 156 p value 
Ward, no. (%) 
  
<0.01 
  
0.54 
 Ward A 24 (32.4) 587 (9.0) 
  
21 (40.4) 76 (48.7) 
 
 Ward B 36 (48.6) 2,607 (40.1) 
  
25 (48.1) 62 (39.7) 
 
 Intensive care unit 1 14 (18.9) 3,315 (50.9) 
  
6 (11.5) 18 (11.5) 
 
Period of admission, no. (%) 
  
0.26 
   
0.79 
 2016 Jan–Mar 14 (18.9) 1,073 (16.5) 
  
6 (11.5) 32 (20.5) 
 
 2016 Apr–Jun 14 (18.9) 1,172 (18.0) 
  
10 (19.2) 27 (17.3) 
 
 2016 Jul–Sep 11 (14.9) 1,078 (16.6) 
  
11 (21.2) 30 (19.2) 
 
 2016 Oct–Dec 16 (21.6) 1,141 (17.5) 
  
6 (11.5) 13 (8.3) 
 
 2017 Jan–Mar 15 (20.3) 1,058 (16.3) 
  
10 (19.2) 27 (17.3) 
 
 2017 Apr–Jun 4 (5.4) 987 (15.2) 
  
9 (17.3) 27 (17.3) 
 
Median stay in 3 wards, d (range) 55 (20–131) 3 (2–8) <0.01 
 
32 (6–59) 20 (5–49) 0.27 
Median age, y (range) 66.5 (59.0–76.0) 67.0 (57.0–75.0) 0.72 
 
63.5 (57.5–73.0) 66.5 (54.0–77.0) 0.79 
Sex, no. (%) 
  
0.44 
   
0.63 
 M 44 (59.5) 4,197 (64.5) 
  
28 (53.8) 76 (48.7) 
 
 F 30 (40.5) 2,312 (35.5) 
  
24 (46.2) 80 (51.3) 
 
Median Charlson comorbidity 
index (range) 
6 (4.0–7.0) 5 (4.0–7.0) 0.14 
 
6 (4.0–6.5) 6 (3.0–7.0) 0.99 
Comorbidities, no. (%)* 
       
 Solid-organ tumor 18 (24.3) 1,766 (27.1) 0.68 
 
11 (21.2) 53 (34.0) 0.12 
 Diabetes mellitus 11 (14.9) 894 (13.7) 0.91 
 
7 (13.5) 21 (13.5) 0.99 
 Chronic pulmonary disease 9 (12.2) 207 (3.2) <0.01 
 
5 (9.6) 9 (5.8) 0.52 
 Chronic kidney disease 11 (14.9) 618 (9.5) 0.17 
 
8 (15.4) 16 (10.3) 0.45 
 Hematologic malignancy 6 (8.1) 164 (2.5) 0.01 
 
4 (7.7) 9 (5.8) 0.87 
 Dementia 3 (4.1) 147 (2.3) 0.52 
 
2 (3.8) 8 (5.1) 0.99 
 Connective tissue disease 3 (4.1) 253 (3.9) 0.99 
 
3 (5.8) 9 (5.8) 0.99 
 Mild liver disease 2 (2.7) 82 (1.3) 0.56 
 
1 (1.9) 3 (1.9) 0.99 
 Steroid use 23 (31.1) 562 (8.6) <0.01 
 
14 (26.9) 34 (21.8) 0.57 
 Mechanical ventilation 72 (97.3) 1,258 (19.3) <0.01 
 
50 (96.2) 62 (39.7) <0.01 
Antimicrobial exposure, no. (%) 
       
 Penicillin† 5 (6.8) 393 (6.0) 0.99 
 
2 (3.8) 15 (9.6) 0.31 
 1st-generation cephalosporin 2 (2.7) 445 (6.8) 0.24 
 
1 (1.9) 11 (7.1) 0.30 
 2nd-generation cephalosporin 2 (2.7) 184 (2.8) 0.99 
 
2 (3.8) 2 (1.3) 0.56 
 3rd-generation cephalosporin 26 (35.1) 1,089 (16.7) <0.01 
 
15 (28.8) 40 (25.6) 0.79 
 4th-generation cephalosporin 0 1 0.99 
 
0 0 NA 
 Aminoglycoside 13 (17.6) 118 (1.8) <0.01 
 
10 (19.2) 12 (7.7) 0.04 
 Glycopeptide 40 (54.1) 481 (7.4) <0.01 
 
27 (51.9) 40 (25.6) <0.01 
 Linezolid 6 (8.1) 40 (0.6) <0.01 
 
5 (9.6) 5 (3.2) 0.13 
 Carbapenem 42 (56.8) 416 (6.4) <0.01 
 
27 (51.9) 42 (26.9) <0.01 
 Tetracycline 12 (16.2) 58 (0.9) <0.01 
 
5 (9.6) 7 (4.5) 0.30 
 Trimethoprim–sulfamethoxazole 17 (23.0) 245 (3.8) <0.01 
 
11 (21.2) 15 (9.6) 0.05 
 Lincosamide 7 (9.5) 40 (0.6) <0.01 
 
2 (3.8) 2 (1.3) 0.56 
 Macrolide 1 (1.4) 286 (4.4) 0.32 
 
1 (1.9) 4 (2.6) 0.99 
 Fluoroquinolone 43 (58.1) 871 (13.4) <0.01 
 
30 (57.7) 45 (28.8) <0.01 
 Other 5 (6.8) 100 (1.5) <0.01 
 
4 (7.7) 5 (3.2) 0.33 
*May be multiple. 
†Includes aminopenicillin, -lactam/-lactamase inhibitor. 
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mechanisms and susceptibility rates of Elizabethkingia spe-
cies isolated from Severance Hospital in 2010 (11) and 2016 
(7). Recently, the incidence of isolation in this hospital in-
creased significantly, from 0.02 to 0.88 per 1,000 admissions 
during 2009–2017, mainly in the 3 study wards.
We analyzed the risk factors associated with the ac-
quisition of Elizabethkingia species after controlling for 
other confounding variables. Using multivariate analysis, 
we found that the probability of acquiring Elizabethkingia 
species was significantly influenced by whether a patient 
received mechanical ventilation, even after PS matching 
and adjustment for other variables. Although some pre-
vious studies have suggested that mechanical ventilators 
could be a risk factor for colonization or infection with 
Elizabethkingia species, they did not provide a statisti-
cal analysis and included only a small number of patients 
(16,30). In our study, a total of 214 (79.6%) patients from 
among the 269 patients seen during January 2009–June 
2017 received mechanical ventilation, as did 72 (97.3%) 
of 74 case-patients admitted to the 3 study wards during 
January 2016–June 2017. We included a large number of 
cases and tried to control for confounding variables using 
PS matching, thus ensuring that mechanical ventilation is 
related to the acquisition of Elizabethkingia species.
Water or water-related equipment can serve as a water-
borne pathogen reservoir in the hospital environment (31). 
Previous studies also have associated a water source with 
acquisition of Elizabethkingia because of the bacterium’s 
48 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 25, No. 1, January 2019
 
Table 4. Results of univariate and multivariate analysis using conditional logistic regression of risk factors for the acquisition of 
Elizabethkingia species at a tertiary teaching hospital after propensity score matching, Seoul, South Korea* 
Variable 
Univariate analysis 
 
Multivariate analysis† 
OR (95% CI) p value OR (95% CI) p value 
Ward 
    
 Ward A Reference     
 Ward B 0.87 (0.41–1.79) 0.70    
 Intensive care unit 1 0.69 (0.18–2.22) 0.56    
Period of admission      
 2016 Jan–Mar Reference     
 2016 Apr–Jun 8.03 (0.79–81.98) 0.08    
 2016 Jul–Sep 8.87 (0.74–105.84) 0.08    
 2016 Oct–Dec 10.62 (0.64–176.77) 0.10    
 2017 Jan–Mar 8.87 (0.97–81.16) 0.05    
 2017 Apr–Jun 8.34 (0.71–98.76) 0.09    
Median stay in 3 wards, d 1.01 (0.99–1.02) 0.25    
Age, y 1.00 (0.98–1.02) 0.87    
Male sex 1.06 (0.55–2.02) 0.87    
Charlson comorbidity index 0.97 (0.85–1.12) 0.69    
Comorbidities‡      
 Solid organ tumor 0.48 (0.21–1.08) 0.08    
 Diabetes mellitus 0.89 (0.34–2.31) 0.81    
 Chronic pulmonary disease 1.85 (0.55–6.28) 0.32    
 Chronic kidney disease 1.52 (0.60–3.85) 0.38    
 Hematologic malignancy 1.00 (0.25–4.00) 0.99    
 Dementia 0.57 (0.12–2.77) 0.49    
 Connective tissue disease 0.80 (0.21–3.05) 0.75    
 Mild liver disease 1.00 (0.10–9.61) 0.99    
 Steroid use 1.55 (0.62–3.89) 0.35    
 Mechanical ventilation 64.54 (8.76–475.30) <0.01  50.44 (6.74–377.48) <0.01 
Antimicrobial exposure      
 Penicillin§ 0.32 (0.07–1.54) 0.16    
 1st-generation cephalosporin 0.29 (0.03–2.88) 0.29    
 2nd-generation cephalosporin 3.00 (0.42–21.30) 0.27    
 3rd-generation cephalosporin 0.97 (0.46–2.01) 0.93    
 4th-generation cephalosporin NA     
 Aminoglycoside 3.18 (1.21–8.31) 0.02  2.30 (0.62–8.47) 0.21 
 Glycopeptide 3.96 (1.82–8.63) <0.01  1.72 (0.50–5.86) 0.39 
 Linezolid 8.84 (0.97–80.69) 0.05    
 Carbapenem 4.16 (1.99–8.72) <0.01  1.63 (0.55–4.85) 0.38 
 Tetracycline 1.65 (0.42–6.43) 0.47    
 Trimethoprim/sulfamethoxazole 2.11 (0.90–4.91) 0.09    
 Lincosamide 6.00 (0.54–66.17) 0.14    
 Macrolide 0.75 (0.08–6.71) 0.80    
 Fluoroquinolone 3.42 (1.70–6.87) <0.01  2.01 (0.71–5.69) 0.19 
 Other 2.09 (0.48–9.03) 0.33    
*OR, odds ratio; NA, not available. 
†Only variables with p<0.05 in the univariate model were included in the multivariate model. 
‡May be multiple. 
§Includes aminopenicillin, -lactam/-lactamase inhibitor. 
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ability to form a biofilm in moist environments. Balm et al. 
reported the infections of 5 patients in 1 outbreak with E. 
meningoseptica were related to a hand hygiene sink aerator 
(14). Moore et al. identified 30 patients as having acquired 
E. meningoseptica during an outbreak; at least 10 of these 
infections were associated with 5 environmental samples 
isolated from sinks (13). Elizabethkingia can spread from 
a humid environment to the surface of medical devices or 
dry materials by the hands of hospital staff or patients (32). 
In our current study, all 12 environmental isolates shared 
identical PFGE patterns with clinical isolates. Our finding 
is consistent with prior reports that Elizabethkingia acqui-
sition might be related to water sources within the hospital 
environment. In contrast, we could not find any evidence that 
the local mosquitoes of South Korea act as vehicles of Eliza-
bethkingia transmission.
As extended-spectrum β-lactamase–producing bacteria 
have increased, the use of carbapenems has inevitably in-
creased. Previous reports have suggested that antimicrobial 
selective pressure may increase the prevalence of bacteria 
with natural resistance to carbapenems, such as Elizabeth-
kingia species (33,34). Unlike in our univariate analysis, our 
multivariate analysis showed no association between antimi-
crobial exposure to carbapenem and the acquisition of Eliza-
bethkingia. One possible explanation for this finding could 
be that host factors are a more important selection factor than 
the antimicrobial drug in the selection of this strain. Anoth-
er explanation could be that our data lacked the statistical 
power to detect differences in Elizabethkingia acquisition by 
antimicrobial exposure to carbapenem.
Difficulties in eradicating and terminating outbreaks 
of Elizabethkingia caused by a strong biofilm biotype 
have been reported (13,14,35). Furthermore, the failure 
of 1,000-ppm sodium hypochlorite and posthandwashing 
alcohol gel has been documented (34). The acquisition risk 
can be reduced by regular sink flushing and improvements 
to the workflow that minimize contamination (13). 
Fortunately, we succeeded in eliminating Elizabethkingia 
species in ward B in September 2017. After all structures 
from which bacteria were isolated were dismantled, the 
outer surface and inner spaces were cleaned. A sheer force 
was applied using a sodium hypochlorite solution and 
a brush, then structures were reinstalled. In ward B, no 
new patient acquisitions of Elizabethkingia occurred after 
this effort. These findings also support the possibility that 
Elizabethkingia acquisition may be related to water source 
and the contaminated devices. However, a previous study 
documented that Elizabethkingia species have been re-
isolated after a month, even after all contaminated devices 
were replaced (14). Continuous monitoring, including 
surveillance culture systems and education for medical staff, 
may be more important than decontamination in reducing 
the acquisition of and infection with Elizabethkingia.
Among our data on treatment outcomes for true pathogen 
cases, none of the antimicrobial agents used after reporting 
the culture results were related to reducing in-hospital 
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Table 5. Results of univariable and multivariable analyses of risk factors for in-hospital mortality of patients with a true pathogen of 
Elizabethkingia in a tertiary teaching hospital, Seoul, South Korea 
In-hospital mortality Total, n = 30 Survived, n = 20 Died, n = 10 p value 
Median age, y (range) 68.5 (61.0–80.0) 69.5 (60.5–79.5) 66.5 (63.0–80.0) 0.86 
Male sex, no. (%) 19 (63.3) 11 (55.0) 8 (80.0) 0.35 
Patients from the 3 study wards, no. (%) 7 (23.3) 5 (25.0) 2 (20.0) 0.99 
Nosocomial infection, no. (%) 29 (96.7) 19 (95.0) 10 (100.0) 0.99 
Median Charlson comorbidity index (range) 6 (5.0–9.0) 6 (4.5–7.5) 6 (5.0–9.0) 0.93 
Clinical condition 
    
 Median hospitalization day of acquisition (range) 26.5 (13.0–58.0) 20.5 (12.0–32.0) 52.5 (26.0–81.0) 0.03 
 Median length of hospitalization, d (range) 47.5 (29.0–89.0) 38.5 (27.5–67.5) 77.5 (54.0–210.0) 0.04 
 Mechanical ventilation, no. (%) 24 (80.0) 15 (75.0) 9 (90.0) 0.63 
 Steroid use, no. (%) 14 (46.7) 9 (45.0) 5 (50.0) 0.99 
Antimicrobial treatment, no. (%) 
    
 Penicillin* 5 (16.7) 3 (15.0) 2 (20.0) 0.99 
 1st-generation cephalosporin 3 (10) 2 (10.0) 1 (10.0) 0.99 
 2nd-generation cephalosporin 5 (16.7) 4 (20.0) 1 (10.0) 0.86 
 3rd-generation cephalosporin 8 (26.7) 4 (20.0) 4 (40.0) 0.47 
 4th-generation cephalosporin 7 (23.3) 4 (20.0) 3 (30.0) 0.88 
 Aminoglycoside 1 (3.3) 1 (5.0) 0 0.99 
 Glycopeptide 13 (43.3) 6 (30.0) 7 (70.0) 0.09 
 Linezolid 4 (13.3) 2 (10.0) 2 (20.0) 0.85 
 Carbapenem 7 (23.3) 2 (10.0) 5 (50.0) 0.05 
 Tetracycline 8 (26.7) 7 (35.0) 1 (10.0) 0.30 
 Colistin 3 (10) 0 3 (30.0) 0.05 
 Trimethoprim/sulfamethoxazole 7 (23.3) 2 (10.0) 5 (50.0) 0.05 
 Lincosamide 5 (16.7) 1 (5.0) 4 (40.0) 0.06 
 Macrolide 1 (3.3) 0 1 (10.0) 0.72 
 Fluoroquinolone 9 (30) 4 (20.0) 5 (50.0) 0.21 
 Other 5 (16.7) 2 (10.0) 3 (30.0) 0.39 
*Includes aminopenicillin, β-lactam/β-lactamase inhibitor. 
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death. Alternatively, patients treated with carbapenem or 
trimethoprim/sulfamethoxazole had significantly higher in-
hospital death rates. However, this analysis included only 30 
true pathogen cases, and results could not be adjusted for 
other potential confounding factors.
The retrospective and single-center nature of the study 
limited our results. Thus, selection bias might exist in the 
tests performed on environmental samples and mosquito 
samples, and we could not identify the species of bacteria 
that were not stored. It is also difficult to perform additional 
surveillance cultures in the hospital setting because we 
have conducted elimination procedures to manage bacterial 
spread. However, we tried to analyze risk factors for 
Elizabethkingia acquisition by minimizing the selection 
bias using a PS-matched study and multivariate analysis.
Even after controlling for potential biases using 
PS matching analysis, we found mechanical ventilation 
to be an independent risk factor for the acquisition of 
Elizabethkingia species. Because Elizabethkingia infection 
has a high rate of death and is difficult to eliminate, intensive 
prevention of contamination is needed.
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